BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21317855)

  • 1. Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.
    Radtke MA; Fölster-Holst R; Beikert F; Herberger K; Augustin M
    G Ital Dermatol Venereol; 2011 Feb; 146(1):31-45. PubMed ID: 21317855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and comorbidity of psoriasis in children.
    Augustin M; Glaeske G; Radtke MA; Christophers E; Reich K; Schäfer I
    Br J Dermatol; 2010 Mar; 162(3):633-6. PubMed ID: 19922529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processes of psoriasis health care in Germany--long-term analysis of data from the statutory health insurances.
    Augustin M; Glaeske G; Schäfer I; Rustenbach SJ; Hoer A; Radtke MA
    J Dtsch Dermatol Ges; 2012 Sep; 10(9):648-55. PubMed ID: 22525221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.
    Augustin M; Reich K; Glaeske G; Schaefer I; Radtke M
    Acta Derm Venereol; 2010 Mar; 90(2):147-51. PubMed ID: 20169297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood psoriasis--an analysis of German health insurance data.
    Matusiewicz D; Koerber A; Schadendorf D; Wasem J; Neumann A
    Pediatr Dermatol; 2014; 31(1):8-13. PubMed ID: 24111584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of psoriasis among children and adolescents in a large multiethnic cohort in southern California.
    Wu JJ; Black MH; Smith N; Porter AH; Jacobsen SJ; Koebnick C
    J Am Acad Dermatol; 2011 Nov; 65(5):957-64. PubMed ID: 21306784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.
    Velez NF; Wei-Passanese EX; Husni ME; Mody EA; Qureshi AA
    Arch Dermatol Res; 2012 Jan; 304(1):7-13. PubMed ID: 21904925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry.
    Oostveen AM; de Jager ME; van de Kerkhof PC; Donders AR; de Jong EM; Seyger MM
    Br J Dermatol; 2012 Jul; 167(1):145-9. PubMed ID: 22616669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy options for psoriasis in childhood and adolescence].
    Zappel K; Sterry W; Blume-Peytavi U
    J Dtsch Dermatol Ges; 2004 May; 2(5):329-42. PubMed ID: 16281521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of childhood psoriasis: a study of 419 patients from northern India.
    Kumar B; Jain R; Sandhu K; Kaur I; Handa S
    Int J Dermatol; 2004 Sep; 43(9):654-8. PubMed ID: 15357744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug supply for children with psoriasis in Germany.
    Augustin M; Reich K; Glaeske G; Kämpfe S; Radtke MA; Gerdau-Heitmann C; Schicktanz C; Schäfer I
    J Dtsch Dermatol Ges; 2013 Aug; 11(8):751-5. PubMed ID: 23718227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals.
    De Jager ME; Van de Kerkhof PC; De Jong EM; Seyger MM
    J Dermatolog Treat; 2009; 20(5):254-8. PubMed ID: 19418330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.
    Reich K; Griffiths CE
    Arch Dermatol Res; 2008 Nov; 300(10):537-44. PubMed ID: 18784934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance on the diagnosis and clinical management of psoriasis.
    Cohen SN; Baron SE; Archer CB;
    Clin Exp Dermatol; 2012 May; 37 Suppl 1():13-8. PubMed ID: 22486764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of psoriasis in childhood and adolescence - a German expert consensus.
    Sticherling M; Augustin M; Boehncke WH; Christophers E; Domm S; Gollnick H; Reich K; Mrowietz U
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):815-23. PubMed ID: 21585653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
    Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD
    Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood psoriasis.
    Benoit S; Hamm H
    Clin Dermatol; 2007; 25(6):555-62. PubMed ID: 18021892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.
    Augustin M; Krüger K; Radtke MA; Schwippl I; Reich K
    Dermatology; 2008; 216(4):366-72. PubMed ID: 18319601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.